Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway | |
Si‐yu Zeng; Li Yang; Hui‐qin Lu; Qiu‐jiang Yan; Ling Gao; Xu‐ping Qin | |
刊名 | Journal of Cellular and Molecular Medicine |
2019 | |
卷号 | 23期号:6页码:4196-4207 |
关键词 | NADPH oxidase 4 a disintegrin and metalloproteinase-17 extracellular signal-regulated kinase (1/2) hypertensive cardiac hypertrophy rutaecarpine |
ISSN号 | 1582-1838 |
DOI | 10.1111/jcmm.14308 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000470659500037 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5696277 |
专题 | 南华大学 |
作者单位 | 1.[Si‐yu Zeng 2.Hui‐qin Lu] Department of Drug Clinical Trial, Guangdong Second Provincial General Hospital, Guangzhou, China |
推荐引用方式 GB/T 7714 | Si‐yu Zeng,Li Yang,Hui‐qin Lu,et al. Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway[J]. Journal of Cellular and Molecular Medicine,2019,23(6):4196-4207. |
APA | Si‐yu Zeng,Li Yang,Hui‐qin Lu,Qiu‐jiang Yan,Ling Gao,&Xu‐ping Qin.(2019).Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway.Journal of Cellular and Molecular Medicine,23(6),4196-4207. |
MLA | Si‐yu Zeng,et al."Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway".Journal of Cellular and Molecular Medicine 23.6(2019):4196-4207. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论